Literature DB >> 34328532

Impact of the COVID-19 pandemic on nuclear medicine departments in Europe.

Ana Paula Moreira1,2, François Jamar3, Zehra Ozcan4, Doina Piciu5,6, Claudine Als7, Maja Franceschi8, Elin Trägårdh9, Ivana Zagar10, Anna Sowa-Staszczak11, Florent Cachin12,13, Roel Bennink14, Flavio Forrer15, Tom Christian Adamsen16,17, Andreas Fotopolous18, Marika Kalnina19, Lars Thorbjørn Jensen20, Hanna Mussalo21, Milan Simanek22, Lina Garcia-Cañamaque23, Sergei Nazarenko24, Jasna Mihailovic25,26, Zvi Bar-Sever27, Martin O'Connell28, Daniela Miladinova29, Richard Graham30, Raffaele Giubbini31, Lucia Kaliská32, Damir Rozić33, Bernd J Krause34, Hans-Jürgen Gallowitsch35, Tamás Györke36, Severina Sediene37, Pavel Rumyantsev38, Wolfgang Wadsak39, Jolanta Kunikowska40.   

Abstract

Entities:  

Year:  2021        PMID： 34328532     DOI： 10.1007/s00259-021-05484-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe.

Authors:  Richard Graham; Ana P Moreira; Andor W J M Glaudemans; Lars Thorbjørn Jensen; Jasna Mihaïlovic; Sergei Nazarenko; Zehra Ozcan; Doina Piciu; Wolfgang Wadsak; Jolanta Kunikowska; François Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08       Impact factor: 10.057

2.  Nuclear Medicine During the COVID-19 Pandemic: The Show Must Go On.

Authors:  Giorgio Treglia
Journal:  Front Med (Lausanne)       Date:  2022-05-12

3.  Challenges and possibilities for board exams in the Covid-19 era: experience from the Fellowship Committee of European Board of Nuclear Medicine.

Authors:  Zehra Ozcan; Ilona Kulakiene; Sofia C Vaz; Jose R Garcia Garzon; Ariane Boubaker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04       Impact factor: 9.236
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.